These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 21972227)

  • 1. Antimalaria drug offers antitumor strategies.
    Hede K
    J Natl Cancer Inst; 2011 Oct; 103(20):1490-1. PubMed ID: 21972227
    [No Abstract]   [Full Text] [Related]  

  • 2. Bypassing phase 1 trials in the cancer drug development paradigm: generally unwise and potentially dangerous.
    Markman M
    Cancer; 2010 Nov; 116(22):5116-8. PubMed ID: 20665504
    [No Abstract]   [Full Text] [Related]  

  • 3. Novel applications for an established antimalarial drug: tumoricidal activity of quinacrine.
    Yan H; Bian A; Gao X; Li H; Chen Z; Liu X
    Future Oncol; 2018 Jun; 14(15):1511-1520. PubMed ID: 29380639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lymphoma researchers in search of molecular targets.
    Friedrich MJ
    J Natl Cancer Inst; 2010 Jul; 102(14):1000-1. PubMed ID: 20616351
    [No Abstract]   [Full Text] [Related]  

  • 5. Anti-Cancer Stem Cells Potentiality of an Anti-Malarial Agent Quinacrine: An Old Wine in a New Bottle.
    Das B; Kundu CN
    Anticancer Agents Med Chem; 2021; 21(4):416-427. PubMed ID: 32698746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase I studies of chemotherapeutic agents in cancer patients: a review of the designs.
    Potter DM
    J Biopharm Stat; 2006; 16(5):579-604. PubMed ID: 17037260
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quinacrine: New anti-tumor application for an old anti-malaria drug.
    Mollapour M; Neckers L
    Cell Cycle; 2010 Jan; 9(2):228. PubMed ID: 20061796
    [No Abstract]   [Full Text] [Related]  

  • 8. Disrupting cancer cells' biocircuits with interactome-based drugs: is 'clinical' innovation realistic?
    Roukos DH
    Expert Rev Proteomics; 2012 Aug; 9(4):349-53. PubMed ID: 22967071
    [No Abstract]   [Full Text] [Related]  

  • 9. Paclitaxel combination therapy in the treatment of metastatic breast cancer: a review.
    Holmes FA
    Semin Oncol; 1996 Oct; 23(5 Suppl 11):46-56. PubMed ID: 8893900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin 1 trials in cancer patients: a review of the toxicity, antitumor and hematopoietic effects.
    Veltri S; Smith JW
    Stem Cells; 1996 Mar; 14(2):164-76. PubMed ID: 8991536
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of pharmacokinetic and pharmacodynamic studies in the planning of protocols for the treatment of childhood cancer.
    Burke GA; Estlin EJ; Lowis SP
    Cancer Treat Rev; 1999 Feb; 25(1):13-27. PubMed ID: 10212587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Q&A: Geoffrey Shapiro on phase I drug trials. Spoke with Suzanne Rose.
    Shapiro G
    Cancer Discov; 2013 Oct; 3(10):1089. PubMed ID: 24124216
    [No Abstract]   [Full Text] [Related]  

  • 13. Inducing indigestion: companies embrace autophagy inhibitors.
    Garber K
    J Natl Cancer Inst; 2011 May; 103(9):708-10. PubMed ID: 21515831
    [No Abstract]   [Full Text] [Related]  

  • 14. Inhibitors of farnesyltransferase: a rational approach to cancer chemotherapy?
    Bell IM
    J Med Chem; 2004 Apr; 47(8):1869-78. PubMed ID: 15055985
    [No Abstract]   [Full Text] [Related]  

  • 15. [Current status and issues in clinical trials of anticancer agents].
    Kojima H
    Gan To Kagaku Ryoho; 1994 Oct; 21 Suppl 3():295-301. PubMed ID: 7986107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical studies with modulators of multidrug resistance.
    Fisher GA; Sikic BI
    Hematol Oncol Clin North Am; 1995 Apr; 9(2):363-82. PubMed ID: 7642468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [LY231514. A multitargeted antifolate (MTA)].
    Lansiaux A; Degardin M; Bailly C
    Bull Cancer; 1999 Sep; 86(9):727-31. PubMed ID: 10519965
    [No Abstract]   [Full Text] [Related]  

  • 18. Targeted agents: the rules of combination.
    Kwak EL; Clark JW; Chabner B
    Clin Cancer Res; 2007 Sep; 13(18 Pt 1):5232-7. PubMed ID: 17875749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EORTC-NCI-AACR - 18th Symposium - Molecular Targets and Cancer Therapeutics.
    Kibble A
    IDrugs; 2007 Jan; 10(1):1-2. PubMed ID: 17187301
    [No Abstract]   [Full Text] [Related]  

  • 20. New microtubule-inhibiting anticancer agents.
    Chen SM; Meng LH; Ding J
    Expert Opin Investig Drugs; 2010 Mar; 19(3):329-43. PubMed ID: 20141350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.